NVAX Covered Call Strategy
NVAX (Novavax, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Novavax, Inc. is a biotechnology firm dedicated to discovering, developing, and commercializing vaccines aimed at preventing serious infectious diseases and addressing critical health needs. The company's diverse pipeline includes NVX-CoV2373, a coronavirus vaccine candidate currently undergoing two Phase III trials, one Phase IIb, and one Phase I/II trial. Also featured is NanoFlu, a nanoparticle-based seasonal quadrivalent influenza vaccine in Phase 3 clinical trials. Furthermore, Novavax is advancing ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine, which is in Phase II clinical trials for adults aged 60 and older, and in Phase I for pediatric use. The company holds a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of its COVID-19 vaccine candidate, NVX-CoV2373. Established in 1987, Novavax, Inc. is headquartered in Gaithersburg, Maryland.
NVAX (Novavax, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.46B, a beta of 2.41 versus the broader market, a 52-week range of 6.2-11.97, average daily share volume of 4.8M, a public-listing history dating back to 1995, approximately 952 full-time employees. These structural characteristics shape how NVAX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 2.41 indicates NVAX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a covered call on NVAX?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current NVAX snapshot
As of June 29, 2026, spot at $9.18, ATM IV 82.83%, IV rank 27.79%, expected move 23.75%. The covered call on NVAX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 32-day expiry.
Why this covered call structure on NVAX specifically: NVAX IV at 82.83% is on the cheap side of its 1-year range, which means a premium-selling NVAX covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 23.75% (roughly $2.18 on the underlying). The 32-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated NVAX expiries trade a higher absolute premium for lower per-day decay. Position sizing on NVAX should anchor to the underlying notional of $9.18 per share and to the trader's directional view on NVAX stock.
NVAX covered call setup
The NVAX covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With NVAX near $9.18, the first option leg uses a $9.50 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed NVAX chain at a 32-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 NVAX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $9.18 | long |
| Sell 1 | Call | $9.50 | $0.70 |
NVAX covered call risk and reward
- Net Premium / Debit
- -$848.00
- Max Profit (per contract)
- $102.00
- Max Loss (per contract)
- -$847.00
- Breakeven(s)
- $8.48
- Risk / Reward Ratio
- 0.120
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
NVAX covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on NVAX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -99.9% | -$847.00 |
| $2.04 | -77.8% | -$644.14 |
| $4.07 | -55.7% | -$441.27 |
| $6.10 | -33.6% | -$238.41 |
| $8.12 | -11.5% | -$35.54 |
| $10.15 | +10.6% | +$102.00 |
| $12.18 | +32.7% | +$102.00 |
| $14.21 | +54.8% | +$102.00 |
| $16.24 | +76.9% | +$102.00 |
| $18.27 | +99.0% | +$102.00 |
When traders use covered call on NVAX
Covered calls on NVAX are an income strategy run on existing NVAX stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
NVAX thesis for this covered call
The market-implied 1-standard-deviation range for NVAX extends from approximately $7.00 on the downside to $11.36 on the upside. A NVAX covered call collects premium on an existing long NVAX position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether NVAX will breach that level within the expiration window. Current NVAX IV rank near 27.79% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on NVAX at 82.83%. As a Healthcare name, NVAX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to NVAX-specific events.
NVAX covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. NVAX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move NVAX alongside the broader basket even when NVAX-specific fundamentals are unchanged. Short-premium structures like a covered call on NVAX carry tail risk when realized volatility exceeds the implied move; review historical NVAX earnings reactions and macro stress periods before sizing. Always rebuild the position from current NVAX chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on NVAX?
- A covered call on NVAX is the covered call strategy applied to NVAX (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With NVAX stock trading near $9.18, the strikes shown on this page are snapped to the nearest listed NVAX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are NVAX covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the NVAX covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 82.83%), the computed maximum profit is $102.00 per contract and the computed maximum loss is -$847.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a NVAX covered call?
- The breakeven for the NVAX covered call priced on this page is roughly $8.48 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current NVAX market-implied 1-standard-deviation expected move is approximately 23.75%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on NVAX?
- Covered calls on NVAX are an income strategy run on existing NVAX stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current NVAX implied volatility affect this covered call?
- NVAX ATM IV is at 82.83% with IV rank near 27.79%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.